Press release
Myocardial Ischemia Market Trends Analysis, Market Opportunities, Key Players, Share And Forecast To 2033
Myocardial Ischemia Market Trends
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=16488&type=smp
According to The Business Research Company's, The myocardial ischemia market size has grown strongly in recent years. It will grow from $0.74 billion in 2023 to $0.79 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to utilization of telemedicine and remote monitoring, development of novel reperfusion therapies for mi, increased cases of obesity, increased cases of high blood pressure, increase in cases of heart attacks.
The myocardial ischemia market size is expected to see strong growth in the next few years. It will grow to $1.04 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to prevalence of various heart-related diseases, growing awareness of the population about cardiovascular diseases, constantly changing lifestyles of people, rising cases of diabetes, rising healthcare expenditure. Major trends in the forecast period include adoption of myocardial ischemia treatments, better healthcare infrastructures, advancements in treatment options, integration of digital health solutions, launches of cardiac rehabilitation programs.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/myocardial-ischemia-global-market-report
Market Drivers and Trends:
The rising incidence of diabetes is expected to propel the growth of the myocardial ischemia market going forward. Diabetes refers to a group of metabolic disorders that involve the body's inability to produce or effectively use insulin, a hormone produced by the pancreas that regulates blood sugar levels. The rising incidence of diabetes is due to obesity and severe obesity, a lack of physical activity, and genetic factors. The growing prevalence of diabetes contributes to the higher incidence of myocardial ischemia, leading to increased demand for diagnostic, therapeutic, and management solutions for myocardial ischemia. For instance, in 2021, according to the International Diabetes Federation (IDF), a UK-based umbrella organization of over 240 national diabetes associations, there were approximately 537 million adults aged 20-79 living with diabetes worldwide 2021, which is expected to rise to 643 million by 2030 and 783 million by 2045. Therefore, the rising incidence of diabetes is a driver for the myocardial ischemia market.
Major companies operating in the myocardial ischemia market are developing innovative drugs such as Lodoco (colchicine) to reduce inflammation and lower the risk of cardiovascular events in patients with coronary artery disease. Lodoco is indicated to reduce the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or with multiple risk factors for cardiovascular disease. For instance, in June 2023, Agepha Pharma, a US-based pharmaceutical company, launched Lodoco (colchicine), approved by the Food and Drug Administration, a US-based government agency. This approval marks the first FDA-approved treatment targeting cardiovascular inflammation. It is based on data from the LoDoCo2 trial, which demonstrated a 31% relative reduction in the risk of cardiovascular events with colchicine 0.5 mg once daily compared to placebo. Lodoco is prescribed to lower the risk of myocardial infarction (MI), stroke, coronary revascularization, and cardiovascular death in adult patients with established atherosclerotic disease or multiple cardiovascular risk factors.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Major Key Players of the Market:
Cardinal Health Inc., Pfizer Inc., Roche Holding AG, Bayer AG, Sanofi SA, Novartis AG, Bristol-Myers Squibb Company, AstraZeneca Plc, Abbott Laboratories Inc., Eli Lilly and Company, Novo Nordisk A/S, Medtronic Plc, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Siemens Healthineers AG, Merck KGaA, GE HealthCare Technologies Inc., Fujifilm Holdings Corporation, Baxter International Inc., Regeneron Pharmaceuticals Inc., Boston Scientific Corporation, Daiichi Sankyo Company Limited, Canon Medical Systems Corporation
Myocardial Ischemia Market 2024 Key Insights:
• The myocardial ischemia market size is expected to see strong growth in the next few years. It will grow to $1.04 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%.
• Diabetes Epidemic Fuels Myocardial Ischemia Market Growth
• Innovative Approaches In Myocardial Ischemia Treatment With FDA Approval of Lodoco (Colchicine) Highlights New Era In Cardiovascular Care
• North America was the largest region in the myocardial ischemia market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=16488&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Myocardial Ischemia Market Trends Analysis, Market Opportunities, Key Players, Share And Forecast To 2033 here
News-ID: 3714909 • Views: …
More Releases from The Business Research Company
Leading Companies Fueling Growth and Innovation in the Running Shoes Market
The running shoes market has experienced remarkable growth recently, driven by evolving consumer preferences and technological advancements. As more people prioritize fitness and comfort, the market is positioned for further expansion. Let's explore the current market size, key players, driving forces, and future trends shaping this industry.
Running Shoes Market Size and Growth Projections
The running shoes market demonstrated robust growth over the past few years, expanding from $50.98 billion…
Key Trends and Emerging Changes Shaping the Wood Products Market Landscape
The wood products industry has been witnessing significant expansion, driven by various factors influencing demand and production. Understanding the current market scale, key players, and emerging trends offers a clearer picture of how this sector is evolving and what lies ahead by 2029.
Projected Growth of the Wood Products Market Size by 2029
The wood products market has experienced robust growth in recent years and is anticipated to continue on…
Segment Evaluation and Major Growth Areas in the Cannabis Vaporizers Market
The cannabis* vaporizers market has witnessed significant expansion recently, driven by changing perceptions and regulatory landscapes surrounding cannabis* use. As more regions legalize cannabis* and consumers become increasingly health-conscious, the demand for safer alternatives to traditional smoking methods continues to rise. Let's explore the current market size, key players, emerging trends, and segmentation insights shaping this evolving industry.
Steady Growth Outlook for the cannabis* Vaporizers Market by 2029
The cannabis*…
Emerging Growth Patterns Driving the Expansion of the Window Film Market
The window film industry has been experiencing significant growth, driven by evolving building technologies and increasing consumer awareness. As demand rises for smarter, more sustainable, and safer architectural solutions, the market is set to expand further in the coming years. Below, we explore the current market size, key players, technological developments, and the trends shaping the window film sector.
Window Film Market Size and Projected Growth Through 2029
The window…
More Releases for Myocardial
Driving Myocardial Infarction Market Growth in 2025: The Role of Increasing Numb …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Myocardial Infarction Market Size Growth Forecast: What to Expect by 2025?
Over the past few years, there has been a significant rise in the size of the myocardial infarction market. It is projected to expand from $2.05 billion in 2024 to $2.2 billion in 2025, exhibiting a compound annual…
Diabetes Epidemic Fuels Myocardial Ischemia Market Growth: An Emerging Driver Tr …
The Myocardial Ischemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Myocardial Ischemia Market?
The myocardial ischemia market has grown strongly. It will grow from $0.79 billion in 2024 to $0.85 billion in 2025 at a CAGR of 7.3%.…
Transforming the Myocardial Ischemia Market in 2025: Diabetes Epidemic Fuels Myo …
What Is the Expected Size and Growth Rate of the Myocardial Ischemia Market?
The market size for myocardial ischemia has demonstrated considerable growth over the last few years. There's a predicted growth from $0.79 billion in 2024 to $0.85 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The substantial growth during the historical period can be credited to the use of telemedicine and remote monitoring, the discovery…
Myocardial Infarction Treatment Market Growth and Insights 2024
"The Business Research Company recently released a comprehensive report on the Global Myocardial Infarction Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Myocardial Infarction Drugs Market
According to a new report published by Allied Market Research, titled, "Myocardial Infarction Drugs Market by Product Type (Analgesics, Antiplatelet Agents, Vasodilators, Thrombolytics, Anti-Thrombotic Agents, Glycoprotein IIb/IIIa Inhibitors, Î' Adrenergic Blockers, Angiotensin Receptor Blockers, and Angiotensin Converting Enzyme Inhibitors) and by Distribution Channel (Hospital Pharmacies, Hospitals, Drug Stores, and Online Drug Stores) - Global Opportunity Analysis and Industry Forecast, 2019-2026".
The Global market size of Myocardial Infarction Drugs Market was $XX…
Myocardial Ischemia - Pipeline Review, H1 2017 - Pharmaceutical Report
Lack of blood flow and oxygen to the heart muscle lead to cardiac ischemia, also called myocardial ischemia. The signs and symptoms may include chest pain, typically on the left side of the body (angina pectoris), neck or jaw pain, shoulder or arm pain, clammy skin, shortness of breath and nausea and vomiting. Myocardial ischemia can be caused by conditions such as coronary artery disease (atherosclerosis), blood clot, coronary spasm…
